Skip to main content
OpenTrials

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,149 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Completed

Evaluation of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis B Infection

NCT00734162

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Children's Hospital & Research Center at Oakland Oakland, California, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • Children's Hospital & Regional Medical Center, d/b/a Seattle Children's Research Institute Seattle, Washington, United States
  • Multiprofile Hospital for Active Treatment Sveti Georgi Plovdiv, Bulgaria
View all 21 locations
View Trial Details
Completed

Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B

NCT01277601

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Asian Pacific Liver Center Los Angeles, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • Research and Education Inc San Diego, California, United States
  • San Jose Gastroenterology San Jose, California, United States
View all 171 locations
View Trial Details
Completed

Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue

NCT01480284

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Chiba, Japan
  • GSK Investigational Site Fukui, Japan
View all 32 locations
View Trial Details
Completed

Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course

NCT01457547

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Bari, Apulia, Italy
  • GSK Investigational Site Galatina (LE), Apulia, Italy
  • GSK Investigational Site Maglie (LE), Apulia, Italy
View Trial Details
Completed

Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants

NCT00514709

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +28 more
Locations
  • City of Muntinlupa, Alabang Junction Alabang, Philippines
  • City of Muntinlupa, Alabang, Philippines
  • City of Muntinlupa, Bayanan Annex, Philippines
  • City of Muntinlupa, Cupang, Philippines
View Trial Details

Related conditions